Recent Articles from GlobeNewswire

LOS ANGELES, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF.

Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time)

– Reports $156 to $160 Million in Preliminary* Full-Year 2025 U.S. Net Product Sales, a 35% to 38% Increase Compared With Full-Year 2024 –

VANCOUVER, British Columbia, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today outlined its strategic priorities and key milestones for 2026. Following a year of significant clinical, operational and financial progress, Zymeworks is focused on executing a long-term strategy designed to maximize value creation for patients, partners, and shareholders.

NEW YORK and PARSIPPANY, N.J., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-'408. IL-15 is a key cytokine involved in multiple immune-mediated disease pathways. Emerging Phase 1b data from the ongoing TEV-‘408 vitiligo study provides preliminary support for IL-15 as a potential therapeutic target to treat a broad variety of autoimmune conditions. Teva anticipates sharing results from TEV-‘408 trials during 2026.

– Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML –

Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on Biomarker Endpoints

PARSIPPANY, N.J., and NEW YORK, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Royalty Pharma plc (Nasdaq: RPRX), today announced a funding agreement of up to $500 million to accelerate the clinical development of Teva’s anti-IL-15 antibody, TEV-’408. IL-15 is a key cytokine involved in multiple immune-mediated disease pathways. Emerging Phase 1b data from the ongoing TEV-‘408 vitiligo study provides preliminary support for IL-15 as a potential therapeutic target to treat a broad variety of autoimmune conditions. Teva anticipates sharing results from TEV-‘408 trials during 2026.

Preliminary 2025 net product revenue of $155.4 million, representing 172% year-over-year growth; OJEMDA 2026 U.S. net product revenue projected to be $225 - $250 million

HealthEx is the first consumer health record integration for Claude by Anthropic to securely link comprehensive medical histories with user privacy and control

VICTORIA, Seychelles, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Bitget has released a comparative review examining trading fees across leading cryptocurrency exchanges, offering a structured overview of how spot and derivatives trading costs differ among major platforms as global trading activity continues to scale.

2025 total revenue expected to exceed $340 million, above the previously guided range of $327-335 million

CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025, in line with prior financial guidance.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today provided an update on its latest progress, developments plans and expected 2026 milestones, which it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California.

TORONTO, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Kepler Communications today announced the successful launch of the first tranche of its optical relay satellites aboard a SpaceX Falcon 9 rocket from Vandenberg Space Force Base, California. The satellites will now begin commissioning as Kepler transitions its optical data relay network into operational service.

New standard creates a common language for agents and systems across the entire shopping journey from discovery and buying to post-purchase experiences

ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2025. In addition, the company provided an update on the previously announced Chief Financial Officer transition.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ardent To Contact Him Directly To Discuss Their Options

NEW YORK, Jan. 10, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 10, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 10, 2026 (GLOBE NEWSWIRE) --

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will close January 13th, 2026

A major gift to the university transforms its hospitality program into the College’s first named school.

LEAWOOD, Kan., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Etienna Bio, Inc., a biotechnology company focused on next-generation autologous and cell-enabled biomaterials for regenerative and aesthetic applications, today announced that it has entered into an exclusive, worldwide license agreement with the UMass Chan Medical School to develop and commercialize a proprietary adipose-derived cellular and matrix technology platform.

DELTA, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”) (TSX.V: AMY | OTCQB: AMYZF | FSE: ID4), a critical minerals refining and lithium-ion battery upcycling company, announces that the Company has granted an aggregate of 3,000,000 stock options to Rob Chang, director, pursuant to the Company’s omnibus equity incentive plan. The stock options have an exercise price of $0.13 per share and an expiry date of January 8, 2031.

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Coupang, Inc. (“Coupang” or the “Company”) (NYSE:CPNG) investors of the February 17, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action.

Nassau, The Bahamas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Bahamas Ministry of Tourism, Investments & Aviation (BMOTIA) proudly celebrates its ongoing partnership with the the Miami Hurricanes as their official destination partner, spotlighting the team’s remarkable 2025-2026 football season.

EVERETT, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Coastal Financial Corporation (Nasdaq: CCB), the holding company for Coastal Community Bank, today announced that it has acquired ownership of the GreenFi brand of climate-friendly consumer financial services products from Mission Financial Partners.

Los Angeles, Jan. 09, 2026 (GLOBE NEWSWIRE) -- WHO: Habitat for Humanity of Greater Los Angeles (Habitat LA) ReBUILD LA Program Homeowner (first family to begin construction) 

Hands-On ReBUILD LA Project Restores Safety, Beauty, and Hope for Uninsured and Underinsured Residents

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) --

Wellness Center Management & Wellness Programming by Cooper

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) --

DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced its partnership with U.S. Neurology Associates (“USNA” or the “Company”), a physician services organization dedicated to transforming community-based neurology care. Through this partnership, USNA will serve neurology practices and their patients across a broad spectrum of neurological indications. Nitin Jain will serve as USNA’s Chief Executive Officer and Brad Hively will serve as Chairman and co-founder. Prior to this role, Nitin Jain served as President of Value Based Care for U.S. Renal Care, and Brad Hively served as CEO of The Oncology Institute (NASDAQ: TOI).

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) --

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) --

NEW YORK, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bleichroeder Acquisition Corp. II (the “Company”) announced today the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the exercise in full by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $287,500,000.

Singapore, Jan. 09, 2026 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD (Nasdaq: WBUY) (the “Company” or “Webuy”) today announced that the Company received a notice from the staff of the Nasdaq Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that it is not in compliance with the minimum of $2,500,000 in stockholders’ equity for continued listing of the Company’s class A ordinary shares of a par value of US$0.0000462 each (the “Class A Ordinary Shares”) on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”) (the “Notification Letter”).

CAMBRIDGE, Mass., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to three new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its fourth quarter and year-end 2025 earnings in a press release to be issued after the market closes on Tuesday, February 3, 2026.

CHARLOTTE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) announced that its Board of Directors has declared a dividend for the first quarter of 2026 of $0.25 per share on shares of the Company's Common Stock and Class B Common Stock payable on February 6, 2026, to stockholders of record as of the close of business on January 23, 2026.

BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on January 2, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 434 shares of its common stock to three new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) --

HONOLULU, Jan. 09, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its fourth quarter 2025 financial results on Friday, January 30, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (8:00 a.m. Hawaii Time).

Sets Date to Report Preliminary Fourth Quarter 2025 Financial Results

TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase and sale of an aggregate of 66,666,666 Class A ordinary shares of the company, no par value per share (the “Shares”)  (or pre-funded warrants in lieu thereof), at a purchase price of $0.15 per share in a registered direct offering. The purchase price for each pre-funded warrant is identical to the purchase price for each Share, less the exercise price of $0.001 per share.

PRESS RELEASE

TAMPA, Fla., Jan. 09, 2026 (GLOBE NEWSWIRE) -- AACSB International today released exposure drafts of its inaugural Global Standards for Business Education and 2026 Accounting Accreditation Standards inviting feedback from business schools, faculty, students, employers, higher education associations, and other stakeholders worldwide.

Shareholders should contact the firm as there may be limited time to enforce your rights.

Theme: Mission Possible 2: Building Community, Uniting A Nation -the Nonviolent Way

New York, New York, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting Majesco’s acquisition of Vitech Systems Group (“Vitech”) and a concurrent refinancing. Majesco, a portfolio company of Thoma Bravo, is a leading provider of cloud-native, AI-native software for insurers in the property and casualty (P&C) and life, annuity and health (L&AH) sectors. Vitech is a complementary provider of cloud-native pension and benefits administration software.

BRISBANE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on January 5, 2026, the Compensation Committee of the Board of Directors of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 228,750 shares of Class A common stock and restricted stock units (RSUs) underlying 116,000 shares of Class A common stock to eighteen (18) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

RUSTON, La., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Origin Bancorp, Inc. (NYSE: OBK) (“Origin”), the financial holding company for Origin Bank, plans to issue fourth quarter and full year 2025 results after the market closes on Wednesday, January 28, 2026, and hold a conference call to discuss such results on Thursday, January 29, 2026, at 8:00 a.m. Central Time (9:00 a.m. Eastern Time). The conference call will be hosted by Drake Mills, Chairman, President and CEO of Origin, William J. Wallace, IV, Chief Financial Officer of Origin, and Lance Hall, President and CEO of Origin Bank.

LAS VEGAS, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Zhejiang Bosuer Motion Apparatus Co., Ltd. (Bosuer), a manufacturer specializing in electric off-road vehicles and an established electric dirt bike supplier, is presenting its latest electric dirt bike innovations at CES 2026, introducing an expanded and refined lineup aimed at accelerating the electrification of the off-road powersports market. At this year’s show, Bosuer is highlighting four core electric off-road motorcycle models — E60, E72, S6 (ES60), and the newly launched S5 — demonstrating the company’s growing technological depth and product breadth in high-performance electric mobility.

Munich, Germany, Jan. 09, 2026 (GLOBE NEWSWIRE) -- On the 31st December 2025, DYWIDAG Systems International (DYWIDAG) completed the sale of 100% of its shares in TAM Groupe (the “Company”), a French market leader in manufacturing and distribution of chemical products, fixing and lifting systems, and accessories for the construction market, to Private Assets SE & Co. KGaA (Private Assets).

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Klarna (KLAR) To Contact Him Directly To Discuss Their Options

Transaction in Own Shares   

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Stride (LRN) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Freeport (FCX) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Firefly (FLY) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Primo Brands (PRMB) To Contact Him Directly To Discuss Their Options

JEFFERSON CITY, Mo., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Central Bancompany, Inc. (Nasdaq: CBC) (“Central Bancompany” or “the Company”), the bank holding company for The Central Trust Bank, will release its fourth quarter 2025 financial results before market hours on Tuesday, January 27, 2026. The Company will host a conference call and webcast at 9:00 a.m. CT on Tuesday, January 27, 2026. The call may include discussion of Company developments, forward-looking statements and other material information about business and financial matters.

PHILADELPHIA, Jan. 09, 2026 (GLOBE NEWSWIRE) --

 Monthly declaration of the total number of shares and voting rights composing the company's capital (at December 31st, 2025)

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Telix (TLX) To Contact Him Directly To Discuss Their Options

NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) today closed its recently announced public offering of 1,945,000 common shares in the capital of the Company (the “Common Shares”) at a price of US$90.00 per Common Share for gross proceeds of US$175,050,000 (the “Offering”). In connection with the Offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 291,750 Common Shares at the public offering price, less underwriting discounts and commissions. All of the securities sold in this Offering were offered by Bright Minds.

SANTIAGO, Chile, Jan. 09, 2026 (GLOBE NEWSWIRE) -- You are cordially invited to participate in Banco Santander Chile's (NYSE: BSAC) conference call-webcast on Thursday February 5, 2026, at 9.00 AM NY time (11.00am Chile time) where we will discuss 4Q 2025 financial results. The Bank's Officers participating in the conference call are: Patricia Pérez, CFO, Cristian Vicuña, Chief Strategy Officer & Head of IR and Lorena Palomeque, Economist. A question and answer session will follow the presentation.

MONTREAL, Jan. 09, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that it set a new monthly record for grain movement in December, marking its fourth consecutive record month. CN moved over 2.82 million metric tonnes of grain from Western Canada last month, surpassing its previous December record set in 2020 by over 80,000 metric tonnes.

DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, at the J.P. Morgan Annual Healthcare Conference (San Francisco).

Hauppauge, NY, Jan. 09, 2026 (GLOBE NEWSWIRE) --  Cemtrex, Inc. (NASDAQ: CETX) (the “Company”), an advanced security technology and industrial services company, today announced that it has entered into a definitive agreement for the purchase of approximately 1,469,507 shares and / or pre funded warrants with a single institutional investor, at a purchase price of $2.722 per share, with gross proceeds to the Company expected to be $4 million to the Company.

BROOKFIELD, Wis., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Infinity Home Services (IHS), a leading home services platform, today announced a leadership transition designed to support the company’s continued growth and long-term strategy.

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against F5, Inc. (“F5” or “the Company”) (NASDAQ: FFIV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Westwood One, Official Network Audio Partner of the NFL, Delivers All the Action with Live Play-by-Play Coverage of All Six NFL Games on Saturday, January 10, Sunday, January 11, and Monday, January 12

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against SLM Corporation a/k/a Sallie Mae (“SLM” or “the Company”) (NASDAQ: SLM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.